IBDEI1OE ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26785,0)
 ;;=G30.0^^110^1286^2
 ;;^UTILITY(U,$J,358.3,26785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26785,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,26785,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,26785,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,26786,0)
 ;;=G30.1^^110^1286^3
 ;;^UTILITY(U,$J,358.3,26786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26786,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,26786,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,26786,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,26787,0)
 ;;=B20.^^110^1286^21
 ;;^UTILITY(U,$J,358.3,26787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26787,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,26787,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,26787,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,26788,0)
 ;;=G10.^^110^1286^22
 ;;^UTILITY(U,$J,358.3,26788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26788,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,26788,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,26788,2)
 ;;=^5003751
 ;;^UTILITY(U,$J,358.3,26789,0)
 ;;=G30.8^^110^1286^1
 ;;^UTILITY(U,$J,358.3,26789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26789,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,26789,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,26789,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,26790,0)
 ;;=A81.89^^110^1286^5
 ;;^UTILITY(U,$J,358.3,26790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26790,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,26790,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,26790,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,26791,0)
 ;;=G20.^^110^1286^26
 ;;^UTILITY(U,$J,358.3,26791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26791,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,26791,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,26791,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,26792,0)
 ;;=G23.1^^110^1286^30
 ;;^UTILITY(U,$J,358.3,26792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26792,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,26792,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,26792,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,26793,0)
 ;;=F03.91^^110^1286^16
 ;;^UTILITY(U,$J,358.3,26793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26793,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,26793,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,26793,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,26794,0)
 ;;=F03.90^^110^1286^18
 ;;^UTILITY(U,$J,358.3,26794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26794,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,26794,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,26794,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,26795,0)
 ;;=G31.84^^110^1286^23
 ;;^UTILITY(U,$J,358.3,26795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26795,1,3,0)
 ;;=3^Mild Cognitive Impairment,So Stated
 ;;^UTILITY(U,$J,358.3,26795,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,26795,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,26796,0)
 ;;=F02.81^^110^1286^14
 ;;^UTILITY(U,$J,358.3,26796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26796,1,3,0)
 ;;=3^Dementia in Other Dis Class Elsewhere w/ Behav Dist
 ;;^UTILITY(U,$J,358.3,26796,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26796,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26797,0)
 ;;=F02.80^^110^1286^15
 ;;^UTILITY(U,$J,358.3,26797,1,0)
 ;;=^358.31IA^4^2
